Int’l Cooperation in Genome Research

KISTI signed an MOU on December 26 with the Samsung Genome Institute and the Center for Biomedical Informatics of Harvard Medical School for joint cancer genome research.
KISTI signed an MOU on December 26 with the Samsung Genome Institute and the Center for Biomedical Informatics of Harvard Medical School for joint cancer genome research.

 

An international cooperation system for cancer genome research has been set up for personalized cancer treatment, prediction, and prevention. 

The National Institute of Supercomputing and Networking of the Korea Institute of Science and Technology Information (KISTI) signed an MOU on December 26 with the Samsung Genome Institute of Samsung Medical Center and the Center for Biomedical Informatics of Harvard Medical School for this purpose. 

According to the agreement, the Center for Biomedical Informatics provides the most advanced genome data analysis technology, while cancer cell genomes collected and produced by the Samsung Genome Institute are transmitted and analyzed by the research networks and supercomputers of KISTI. 

At present, the three organizations are participating in the TCGA Consortium of the United States for renal cancer research. 

“We hope that the agreement will lead to greater cooperation in genome research in Korea,” said Lee Ji-soo, director of the National Institute of Supercomputing and Networking.

Copyright © BusinessKorea. Prohibited from unauthorized reproduction and redistribution